Effect of Carnitine Treatment on HCV in liver cirrhosis patients with hepatitis C virus infectio
Not Applicable
- Conditions
- iver cirrhosis Patients with HCV infection
- Registration Number
- JPRN-UMIN000020300
- Lead Sponsor
- Hokkaido University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with poorly controlled cardiac disease (e.g., myocardial infarction, cardiac failure, arrhythmia) 2)Patients with severe hepatic impairment 3)Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 4)Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of serum HCV titer
- Secondary Outcome Measures
Name Time Method ) Change of oxidant stress maker and blood biochemistry 2)Presence or absence of a reversal of liver fibrosis 3)Presence or absence of an improvement in AFP levels 4)Effects of glucose/lipid-related factors on treatment response 5) Incidence of AEs